Critical care medicine
-
Critical care medicine · Apr 2003
ReviewLung-protective ventilation strategies in acute lung injury.
To review the challenges of providing mechanical ventilatory support for respiratory failure while avoiding ventilator-associated lung injury in patients with acute lung injury. To review the results of several randomized clinical trials of lung-protective ventilation strategies using conventional mechanical ventilators. ⋯ Evidence supports the use of a volume- and pressure-limited approach to mechanical ventilation in patients with acute lung injury. It is not yet clear whether the open-lung approach will further reduce mortality in patients receiving volume- and pressure-limited ventilation support.
-
Critical care medicine · Apr 2003
ReviewHigh-frequency oscillatory ventilation for acute respiratory distress syndrome in adult patients.
High-frequency oscillatory ventilation (HFOV) using an open-lung strategy has been demonstrated to improve oxygenation in neonatal and pediatric respiratory failure, without increasing barotrauma. Animal studies using small (<4 mm) endotracheal tubes have shown reduced histopathologic evidence of lung injury and inflammatory mediator release, suggesting reduced ventilator-induced lung injury. ⋯ Future studies should compare different algorithms of applying HFOV to determine the optimal techniques for achieving oxygenation and ventilation, while minimizing ventilator-associated lung injury. The potential role of adjunctive therapies used with HFOV (e.g., prone ventilation, inhaled nitric oxide, aerosolized vasodilators, liquid ventilation) will require further research.
-
Critical care medicine · Apr 2003
Case Reports Multicenter Study Clinical TrialDetecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine.
Our first objective was to determine a blood lactate threshold predictive of survival in human immunodeficiency virus patients experiencing lactic acidosis related to nucleoside analogs, and second, to test l-carnitine for the treatment of patients exceeding that threshold. ⋯ The blood lactate levels in human immunodeficiency virus patients receiving nucleoside-analog therapy can predict mortality in these patients. The preliminary data from this pilot study suggest that l-carnitine may be helpful for patients who have nucleoside-analog-related lactic acidosis with blood lactate levels >10 mmol/L. Further studies will be necessary to affirm the therapeutic efficacy of l-carnitine in this setting.
-
Critical care medicine · Apr 2003
ReviewPhysiologic rationale for ventilator setting in acute lung injury/acute respiratory distress syndrome patients.
To review the physiologic approach to setting mechanical ventilation in acute lung injury/acute respiratory distress syndrome. ⋯ The majority of physiologic, experimental, and clinical trial data converge on one simple concept: treat the lung gently.
-
Critical care medicine · Apr 2003
ReviewCoagulation, fibrinolysis, and fibrin deposition in acute lung injury.
To review: a) the role of extravascular fibrin deposition in the pathogenesis of acute lung injury; b) the abnormalities in the coagulation and fibrinolysis pathways that promote fibrin deposition in the acutely injured lung; and c) the pathways that contribute to the regulation of the fibrinolytic system via the lung epithelium, including newly recognized posttranscriptional and urokinase-dependent pathways. Another objective was to determine how novel anticoagulant or fibrinolytic strategies may be used to protect against acute inflammation or accelerated fibrosis in acute lung injury. ⋯ Disordered coagulation and fibrinolysis promote extravascular fibrin deposition in acute lung injury. It is this deposition that characterizes acute lung injury and repair. Expression of uPA, uPAR, and PAI-1 by the lung epithelium, as well as the ability of uPA to induce other components of the fibrinolytic system, involves posttranscriptional regulation. These pathways may contribute to disordered fibrin turnover in the injured lung. The success of anticoagulant or fibrinolytic strategies designed to reverse the abnormalities of local fibrin turnover in acute lung injury supports the inference that abnormalities of coagulation, fibrinolysis, and fibrin deposition have a critical role in the pathogenesis of acute lung injury.